共 50 条
- [2] Long-term control of signs and symptoms of rheumatoid arthritis with chimeric monoclonal anti-TNFα antibody (infliximab) in patients with active disease on methotrexate. [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S364 - S364
- [7] 52-WEEK RESULTS OF CLINICAL, RADIOGRAPHIC AND PHARMACOKINETIC ASSESSMENTS: GOLIMUMAB, A HUMAN ANTI-TNF MONOCLONAL ANTIBODY, ADMINISTERED SUBCUTANEOUSLY EVERY FOUR WEEKS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 372 - 372
- [8] 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments: Golimumab, a Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S175 - S175